There is no pinned content in this Editor's Picks module.
Click here to learn more about content pinning.
Sudden death has been reported in association with CNS [central nervous system] stimulant treatment at usual doses in children and adolescents with structural cardiac abnormalities or other serious heart problems.
Catholic News Service (CNS) is no more into lobbying/advocacy than is the Associated Press, NBC, ABC, CBS, PBS or any other news agency.
Endpoints - Clinical Trials in CNS Disorders - Multiple Endpoints and Ratings Scales are Becoming More Widely Adopted
We are helping the biopharmaceutical industry take a major step forward to leverage advanced technologies in the assessment of CNS (central nervous system) diseases
The Journal is pleased to publish this issue which addresses many of the bioengineering advances being made in the field of central nervous system injury. Further, this compendium of manuscripts emphasizes the important, yet underappreciated, fact that biomechanical-induced change distinguishes CNS trau...
UCB New Medicines™ is deploying a wide range of innovative and proprietary science and technologies in its search for breakthrough medicines. Lectus’s drug discovery and development programmes supports our research efforts in the CNS field. I feel confident it will enable us to further honour our commit...
PAREXEL has continued to provide clients with true leadership in early phase CNS drug development—combining the latest technology with our extensive scientific expertise and CNS research tools, including cerebrospinal fluid dynabridging studies
There are no results for this module. Edit this module to change the search term used to query Wikipedia
Sudden death has been reported in association with CNS [central nervous system] stimulant treatment at usual doses in children and adolescents with structural cardiac abnormalities or other serious heart problems.
Catholic News Service (CNS) is no more into lobbying/advocacy than is the Associated Press, NBC, ABC, CBS, PBS or any other news agency.
Endpoints - Clinical Trials in CNS Disorders - Multiple Endpoints and Ratings Scales are Becoming More Widely Adopted
We are helping the biopharmaceutical industry take a major step forward to leverage advanced technologies in the assessment of CNS (central nervous system) diseases
The Journal is pleased to publish this issue which addresses many of the bioengineering advances being made in the field of central nervous system injury. Further, this compendium of manuscripts emphasizes the important, yet underappreciated, fact that biomechanical-induced change distinguishes CNS trau...
UCB New Medicines™ is deploying a wide range of innovative and proprietary science and technologies in its search for breakthrough medicines. Lectus’s drug discovery and development programmes supports our research efforts in the CNS field. I feel confident it will enable us to further honour our commit...
PAREXEL has continued to provide clients with true leadership in early phase CNS drug development—combining the latest technology with our extensive scientific expertise and CNS research tools, including cerebrospinal fluid dynabridging studies
